AZ14170133
Product Sizes
5 mg
£ POA
HY-145399-5MG
100 mg
£ POA
HY-145399-100MG
50 mg
£ POA
HY-145399-50MG
1 mg
£ POA
HY-145399-1MG
10 mg
£ POA
HY-145399-10MG
25 mg
£ POA
HY-145399-25MG
About this Product
- SKU:
- HY-145399
- Additional Names:
- SG 3932; AZ-0133
- Application:
- Antibody Microarray
- CAS Number:
- 2495742-34-0
- Extra Details:
- AZ14170133 (SG 3932; AZ-0133) is a Drug-Linker Conjugates for ADC. AZ14170133 consists of the ADC cytotoxic payload topoisomerase 1 inhibitor and a linker. AZ14170133 can be used for synthesis of ADC AZD9592 (HY-171124) and AZD 8205 (HY-171689). AZ14170133 can be used for the research of cancer[1][2].
- Molecular Weight:
- 1148.26
- Purity:
- 99.73
- References:
- [1]Philip Wilson Howard, et al. Compounds and conjugates thereof. Patent US20200306243A1.|[2]Schmidt, et al. Computer-based scoring method indicating a cancer patient's response to an anti-B7H4 antibody-drug conjugate therapy using a convolutional neural network, WO2022053685, 2022.
- Research Area:
- Cancer
- Shipping Conditions:
- Blue Ice
- Storage Conditions:
- -20[o]C (Powder; sealed storage; away from moisture and light)
- Type:
- Proteins, Peptides, Small Molecules & Other Biomolecules: Conjugated Protein
- Pathway:
- Antibody-drug Conjugate/ADC Related;Cell Cycle/DNA Damage
